Recent advances in alcoholic hepatitis

Frontline Gastroenterology
Jennifer Veryan, E H Forrest

Abstract

Alcoholic hepatitis (AH) is an acute deterioration in liver function seen in the context of prolonged excessive alcohol consumption and is characterised by the rapid onset of jaundice. The diagnosis of AH has been controversial for many years: it is now accepted that there are clear clinical criteria which can be used to diagnose AH without the need for a liver biopsy. Corticosteroids remain the only treatment proven to be effective in reducing short-term mortality in severe AH; abstinence from alcohol is the most important factor in determining long-term survival. It is recommended a trial of corticosteroid therapy is considered only in those patients with high baseline 'static' scores (Glasgow Alcoholic Hepatitis score and model for end-stage liver disease). Response to corticosteroid therapy should be assessed using a 'dynamic' score such as the Lille score at day 7, with corticosteroids continuing only in patients with a favourable score. Infection and acute kidney injury are associated with poorer outcomes in AH. Early screening for and treatment of infection is recommended with antibiotic therapy overlapping with any subsequent corticosteroid treatment. A biomarker which predicts benefit from corticosteroids at baseline w...Continue Reading

References

May 4, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sylvie NaveauUNKNOWN Foie-Alcool group of the Association Française pour l'Etude du Foie
May 24, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexandre LouvetPhilippe Mathurin
May 17, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Ton LismanRobert J Porte
Sep 29, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·José AltamiranoRamón Bataller
Nov 11, 2011·The New England Journal of Medicine·Eric Nguyen-KhacUNKNOWN AAH-NAC Study Group
Nov 11, 2011·The New England Journal of Medicine·Philippe MathurinJean-Charles Duclos-Vallée
Jun 18, 2014·The American Journal of Gastroenterology·Virendra SinghRatiram Sharma
Jan 23, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Thomas SerstéChristophe Moreno
Apr 23, 2015·The New England Journal of Medicine·Mark R ThurszUNKNOWN STOPAH Trial
Dec 7, 2016·The American Journal of Gastroenterology·Mauricio Garcia-Saenz-de-SiciliaAndres Duarte-Rojo
May 2, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexandre LouvetPhilippe Mathurin
Nov 25, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Julie ThompsonUNKNOWN VTI-208 Study Group
Jan 18, 2018·The American Journal of Gastroenterology·Ashwani K SingalVijay H Shah
Jan 26, 2018·Journal of Clinical Gastroenterology·Sukanta DasShiv K Sarin
Mar 9, 2018·Virchows Archiv : an International Journal of Pathology·Saggere Muralikrishna ShasthryShiv Kumar Sarin
Apr 10, 2018·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Apr 16, 2018·Gastroenterology·Brian P LeeNorah A Terrault
Jun 12, 2018·The American Journal of Gastroenterology·Ewan H ForrestMichael Allison
Jun 23, 2018·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Cyriac Abby PhilipsPhilip Augustine
Aug 29, 2018·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ravi SujanAshwani K Singal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Related Papers

Journal of Gastrointestinal and Liver Diseases : JGLD
Felix Stickel, Helmut K Seitz
Hepatobiliary & Pancreatic Diseases International : HBPD INT
Fei Wang, Bing-Yuan Wang
Journal of Gastroenterology and Hepatology
Philippe MathurinSébastien Dharancy
Clinics in Liver Disease
Paulina K Phillips, Michael R Lucey
Gastroenterología y hepatología
Jennifer Casanova, Ramon Bataller
© 2021 Meta ULC. All rights reserved